Correlation Between Ultragenyx and FibroGen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ultragenyx and FibroGen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ultragenyx and FibroGen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ultragenyx and FibroGen, you can compare the effects of market volatilities on Ultragenyx and FibroGen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ultragenyx with a short position of FibroGen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ultragenyx and FibroGen.

Diversification Opportunities for Ultragenyx and FibroGen

-0.22
  Correlation Coefficient

Very good diversification

The 3 months correlation between Ultragenyx and FibroGen is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Ultragenyx and FibroGen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FibroGen and Ultragenyx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ultragenyx are associated (or correlated) with FibroGen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FibroGen has no effect on the direction of Ultragenyx i.e., Ultragenyx and FibroGen go up and down completely randomly.

Pair Corralation between Ultragenyx and FibroGen

Given the investment horizon of 90 days Ultragenyx is expected to under-perform the FibroGen. But the stock apears to be less risky and, when comparing its historical volatility, Ultragenyx is 1.26 times less risky than FibroGen. The stock trades about -0.04 of its potential returns per unit of risk. The FibroGen is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  815.00  in FibroGen on May 7, 2025 and sell it today you would lose (122.00) from holding FibroGen or give up 14.97% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Ultragenyx  vs.  FibroGen

 Performance 
       Timeline  
Ultragenyx 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Ultragenyx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
FibroGen 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Over the last 90 days FibroGen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Ultragenyx and FibroGen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ultragenyx and FibroGen

The main advantage of trading using opposite Ultragenyx and FibroGen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ultragenyx position performs unexpectedly, FibroGen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FibroGen will offset losses from the drop in FibroGen's long position.
The idea behind Ultragenyx and FibroGen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios